AZ’s antibody first to be cleared by FDA for COVID preventionAstraZeneca’s antibody cocktail for COVID-19, now called Evushield, has become the first drug in the class to be Share XAZ’s antibody first to be cleared by FDA for COVID preventionhttps://pharmaphorum.com/news/azs-antibody-first-to-be-cleared-by-fda-for-covid-prevention/
Merck files pill for milder COVID, as AZ showcases its antibody dataAs expected, Merck & Co has moved ahead swiftly with an emergency use application for its oral antiviral Share XMerck files pill for milder COVID, as AZ showcases its antibody datahttps://pharmaphorum.com/news/merck-files-pill-for-milder-covid-as-az-showcases-its-antibody-data/
AZ files for emergency use of COVID-19 antibody combo in USAstraZeneca has sought emergency use authorisation for its antibody combination AZD7442, following trial results indicating it can prevent Share XAZ files for emergency use of COVID-19 antibody combo in UShttps://pharmaphorum.com/news/az-files-for-emergency-use-of-covid-antibody-combo-in-us/
PROVENT trial puts AZ COVID antibody combo back on trackAstraZeneca’s AZD7442 has shown that it can prevent COVID-19 infection when given to healthy patients – the first Share XPROVENT trial puts AZ COVID antibody combo back on trackhttps://pharmaphorum.com/news/provent-trial-puts-az-covid-antibody-combo-back-on-track/
Chasing Regeneron, AZ starts trials of its COVID-19 antibody cocktailThe first patients have been dosed in a trial of two AstraZeneca antibodies, collectively known as AZD7442, that Share XChasing Regeneron, AZ starts trials of its COVID-19 antibody cocktailhttps://pharmaphorum.com/news/chasing-regeneron-az-starts-trials-of-its-covid-19-antibody-cocktail/
